Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,830
datasets available to search
ShareScore release 0.9.0
Dataset results
2,830 results for “Radiation therapy”
A Study of TAK-676 With Pembrolizumab After Radiation Therapy to Treat a Number of Cancers
ClinicalTrials.gov study NCT04879849. IPD Sharing: YES. Countries: 1. Publications: 2.
A Phase 1b/2 Study of PLX3397 + Radiation Therapy + Temozolomide in Patients With Newly Diagnosed Glioblastoma
ClinicalTrials.gov study NCT01790503. IPD Sharing: YES. Countries: 1. Publications: 2.
Data for 'Simulating Photodynamic Therapy for the Treatment of Glioblastoma using Monte Carlo Radiative Transport'
<p>Files added include the data used to make each data plot within the paper.</p> <p>Figure 5:</p> <p>pen_depth_plot.py</p> <p>pen_depth_plot_y.py</p> <p>pen_depth_plot_z.py</p> <p>jmean_run2NB.dat</p> <p>o21_full_run2NB.dat</p> <p>rhokap_run2NB.dat</p> <p>tumour.dat</p> <p> </p> <p>Figure 6:</p> <p>tumour_percentage.py</p> <p>tumkill_full_994.dat</p> <p>tumkill_full_1.dat</p> <p> </p> <p>Figure 7:</p> <p>temp_run2NB.dat</p> <p>max_temp_timeNB.dat</p> <p> </p> <p>Figure 8:</p> <p>power_run2NB.dat</p> <p>s0_slice_run2NB.dat</p> <p>o23_slice_run2NB.dat</p> <p>o21_slice_run2NB.dat</p> <p>temp_slice_run2NB.dat</p> <p> </p> <p>Figure 9:</p> <p>percent_left_run2NB.dat</p> <p>percent_left_run11NB.dat</p> <p>percent_left_run12NB.dat</p> <p>percent_left_run13NB.dat</p> <p> </p> <p>Figure 10:</p> <p>percent_left_run1NB.dat</p> <p>percent_left_run2NB.dat</p> <p>percent_left_run3NB.dat</p> <p>percent_left_run4NB.dat</p> <p> </p> <p>Figure 11:</p> <p>max_temp_time_run1NB.dat</p> <p>max_temp_timeNB.dat</p> <p>percent_left_run1NB.dat</p> <p>percent_left_run2NB.dat</p> <p> </p> <p>Figure 12:</p> <p>percent_left_run2NB.dat</p> <p>percent_left_run10NB.dat</p> <p>max_temp_time_run10NB.dat</p> <p>max_temp_timeNB.dat</p> <p> </p> <p>Figure 13:</p> <p>percent_left_run2NB.dat</p> <p>max_temp_timeNB.dat</p> <p>percent_left_run9NB.dat</p> <p>max_temp_time_run9NB.dat</p> <p> </p> <p>Figure 14:</p> <p>percent_left_run2NB.dat</p> <p>percent_left_run14NB.dat</p> <p>percent_left_run15NB.dat</p> <p> </p> <p>Figure 15:</p> <p>percent_left_run2NB.dat</p> <p>percent_left_run56NB.dat</p> <p>percent_left_run62NB.dat</p> <p>max_temp_time_run56NB.dat</p> <p>max_temp_timeNB.dat</p> <p> </p>
Impact of New Developments in the Commissioning of Operational Radiation Protección in Compact Proton Therapy Centers (CPTC)
<p>Proton therapy is in continuous ever evolving to improve its performance. Some prominent current trends involve cutting-edge delivery methods or building compact proton centers. New developments have a direct impact in radiation protection of proton facilities and actions should be developed continuously with the aim that new centers meet all the requirements. The study of radiological protection in multi-room centers has been widely studied elsewhere, however, compact centers have specific features that pose a challenge in radiation protection, and the present work suggest different contributions to the body of knowledge in these compact facilities. Compact Proton Therapy Centers (CPTC) act out latest advances in particles: Usually have one single room, small footprint and a standard configuration, higher radiation density (Sv/m<sup>2</sup>), using the most advanced equipment and machinery to reduce their size, the delivery mode of protons is Pencil Beam Scanning (PBS), and there is a mix of professional exposed workers (clinical and technical staff) in these centers.</p> <p>The present work is framed into the project Contributions to operational radiation protection and neutron dosimetry in compact proton therapy centers (CPTC), which is focused on assessing the impact of these innovations on the operational radiation protection and commissioning of the compact facilities. Thus, several tasks have been carried out over the last three years, as checking and evaluation of shielding, comparing ambient dose equivalent of several CPTC, analyzing activation with different types of concrete, and activation in machinery, air and water of the facility, characterizing wide range rem-meters and neutron area monitors to measure neutron fields, studying new proton delivery techniques and their neutron fields, or assessing personal dosemeters, among others. The aim of the work is to present outcomes achieved in the aforementioned areas. As a result, a commissioning process of the operational radiation protection in compact centers will be suggested, lined up with the requirements by the Spanish Regulatory Body.</p> <p>Considering topics as new methods of application of dose in development (proton arc therapy, flash-therapy with protons), new materials for barriers and shielding or recent radiation monitoring equipment, future works must be carried out to study their impact on operational radiation protection and recommendations such as ICRP Publication 127, Radiological Protection in Ion Beam Radiotherapy, should be updated periodically taking into account the new methods and technologies developed.</p>
Peripheral blood TCRseq data in AIRR-C format for cancer patients who received either photon or proton based radiation therapy
<p>These are the AIRR-C format converted data from the original Adaptive ImmunoSEQ v2 data format.</p> <p>See the analysis repo for more information: <a href="https://github.com/JamieHeather/radiation-induced-lymphopenia-paper-analysis" target="_blank" rel="noopener">https://github.com/JamieHeather/radiation-induced-lymphopenia-paper-analysis</a>.</p>
Microhardness for SDF group after Radiation Therapy
<p>The table shows microhardness values of 11 samples of SDF group after Radiation Therapy. Each microhardness value was determined by assessing 5 different sites on the enamel surface and the final SMH was noted.</p> <p>The microhardness for the SDF group ranged from 214.5-309.9 HV.</p> <p> </p>
Microhardness of control group teeth after Radiation Therapy
<p>The table shows microhardness values of 11 samples of control group after Radiation Therapy. Each microhardness value was determined by assessing 5 different sites on the enamel surface and the final SMH was noted.The microhardness values for the control group ranged from 70.68 - 93.44 HV.</p>
Post COVID-19 trends in simulation use within diagnostic radiography and radiation therapy education.
<p>The authors developed and deployed an online survey among diagnostic radiography and/or radiation therapy educators with experience in pre-registration training (academic, clinical or combined).The aim of this study was to capture global trends and activity on simulation-based education (SBE) in medical imaging and radiation therapy education. Simulation is a well-established component of medical radiation science training that embraces a wide range of activities and resources all aiming to provide a safe environment in which to practice clinical skills. The survey instrument design was informed by a prior review of the literature, a previous international survey conducted by members of the research team<sup>1</sup> and experience within the research team. It comprised two open and 27 closed questions designed to ascertain data across four domains: type of training environment of the respondent (n=13), access to and use of simulation within the participants’ institution (n=13) and possible future trends in simulation (n=3). Data captured in this study was compared with similar data from Bridge and colleagues previous survey in 2020.<sup>1 </sup>There is an opportunity for this dataset to add to the evidence base on the evolving landscape of the use of SBE in radiography/radiation therapy education. Such information has the potential to inform future practices and to create best-practice standards in the adoption of simulation-based educational resources and activities in diagnostic radiography and radiation therapy.</p> <p>Reference:</p> <ol> <li>Bridge P, Shiner N, Bolderston A, et al. International audit of simulation use in pre-registration medical radiation science training. <em>Radiography (Lond)</em>. Nov 2021;27(4):1172-1178. doi:10.1016/j.radi.2021.06.011</li> </ol>
Lung Volume Reduction for Severe Emphysema by Stereotactic Ablative Radiation Therapy
ClinicalTrials.gov study NCT03673176. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
ClinicalTrials.gov study NCT00769379. IPD Sharing: Not stated. Countries: 4. Publications: 2.
Testing the Addition of a Radiation Sensitizing Drug, IPdR, to the Usual Chemotherapy Treatment (Capecitabine) During Radiation Therapy for Rectal Cancer
ClinicalTrials.gov study NCT04406857. IPD Sharing: YES. Countries: 1. Publications: 1.
Radiation Therapy, Paclitaxel, and Cisplatin in Treating Patients With Cancer of the Cervix
ClinicalTrials.gov study NCT00003377. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors
ClinicalTrials.gov study NCT00047320. IPD Sharing: Not stated. Countries: 5. Publications: 1.
Triapine, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer or Vaginal Cancer
ClinicalTrials.gov study NCT00941070. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer
ClinicalTrials.gov study NCT00116142. IPD Sharing: NO. Countries: 1. Publications: 4.
Stereotactic MRI-guided Adaptive Radiation Therapy (SMART) in One Fraction
ClinicalTrials.gov study NCT04939246. IPD Sharing: NO. Countries: 1. Publications: 1.
Image-Guided Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Shoulder, Arm, Hip, or Leg
ClinicalTrials.gov study NCT00589121. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
ClinicalTrials.gov study NCT02927249. IPD Sharing: Not stated. Countries: 4. Publications: 2.
BMS-986156, Ipilimumab, and Nivolumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Lung/Chest or Liver Cancers
ClinicalTrials.gov study NCT04021043. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov study NCT00005044. IPD Sharing: Not stated. Countries: 2. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.